RT Journal Article
SR Electronic
T1 Basic Reproduction Rate and Case Fatality Rate of COVID-19: Application of Meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.13.20100750
DO 10.1101/2020.05.13.20100750
A1 Yadav, Suryakant
A1 Yadav, Pawan Kumar
YR 2020
UL http://medrxiv.org/content/early/2020/05/16/2020.05.13.20100750.abstract
AB Background The outbreak of novel coronavirus disease of 2019 (COVID-19) has a wider geographical spread than other previous viruses such as Ebola and H1N1. The onset of disease and its transmission and severity has become a global concern. The policymakers have a serious concern for containing the spread and minimising the risk of death.Aim This study aims to provide the estimates of basic reproduction rate (R0) and case fatality rate (CFR) which applies to a generalised population.Methods A systematic review was carried out to retrieve the published estimates of reproduction rate and case fatality rate in peer-reviewed articles from PubMed MEDLINE database with defined inclusion and exclusion criteria in the period 15 December 2019 to 3 May 2020. The systematic review led to the selection of 24 articles for R0 and 17 articles for CFR. These studies used data from China and its provinces, other Asian countries such as Japan, Korea, the Philippines, and countries from other parts of the world such as Nigeria, Iran, Italy, Europe as a whole, France, Latin America, Turkey, the United Kingdom (UK), and the United States of America (USA). These selected articles gave an output of 30 counts of R0 and 29 counts of CFR which were used in a meta-analysis. A meta-analysis, with the inverse variance method, fixed- and random-effects model and the Forest plot, was performed to estimate the mean effect size or mean value of basic reproduction rate and case fatality rate. The Funnel plot is used to comprehend the publication bias.Results We estimated the robust estimate of R0 at 3.11 (2.49–3.71) persons and the robust estimate of CFR at 2.56 (2.06–3.05) per cent after accounting for heterogeneity among studies, using the random-effects model. The regional subgroup analysis in a meta-analysis was significant for R0 but was not significant for CFR. The R0 values varied from 1.90 (1.06–2.74) persons to 3.83 (2.44–5.22) persons across the regions. The Funnel plot confirms that the selected studies are significant at one per cent level of significance.Conclusion We found that one person is likely to infect two to three persons in the absence of any control measures, and around three per cent of the population are at the risk of death within one-and-a-half months from the onset of disease COVID-19 in a generalised population. The emergence of SARS-CoV-2 varies across regions, but the risk of death remains the same.Contribution The estimates of R0 and CFR are independent of data from a particular region or time or a homogeneous population. These estimates are applicable to a generalised population. Therefore, the estimates of R0 and CFR are unequivocally applicable to developing country like India and its states or districts, in ambivalence. The assessments of R0 and CFR values across the developed nations make all of us aware of consequences of COVID-19, and hence these estimates are of crucial importance for government authorities for the practical implementation of strategies and control measures to contain the disease.Research HighlightsThe robust estimate of Basic Reproduction Rate (R0) of COVID-19 based on a meta-analysis performed on the pieces of evidence available across countries is 3.11 (2.49–3.71) persons for a generalised population in the absence of any control measuresThe robust estimate of Case Fatality Rate (CFR) based on a meta-analysis performed on the pieces of evidence available across countries equals to 2.56 (2.06–3.05) per cent for a generalised population in approximately one-and-a-half months from the onset of the disease COVID-19.A significant regional variation is evident for the Basic Reproduction Rate (R0) but not for the Case Fatality Rate (CFR)The peer-reviewed articles with a small sample size do not suffer from publication bias in a meta-analysis of COVID-19.Added Value of this StudyOut study combine available evidence of the parameter values, such as reproduction rate and case fatality rate, of the generalised epidemiological models for coronavirus disease of 2019 (COVID-19). In this way, we have reduced the dependency on data from a particular region or time or a homogeneous population. By applying meta-analysis, we estimated the robust estimate of reproduction rate and case fatality rate, which is applicable across heterogeneous populations. We proclaim that the reproduction rate of COVID-19 varies across subgroups of populations and regions and periods, but the case fatality rate remained the same. These estimates of reproduction rate and case fatality rate are worthwhile for developing countries like India and at a lower level of geography, in ambivalence.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is based on published Literatures so it is not registered for clinical trail.Funding StatementNoAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis Article is based on Published Literature search through PubMed MEDLINE, Endnote and Google Scholar.